Schrödinger, Inc. Profile Avatar - Palmy Investing

Schrödinger, Inc.

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The …
Medical - Healthcare Information Services
US, New York [HQ]

Balance Sheet

7 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2017 2018 2019 2020 2021 2022 2023
Assets
58.00 120.00 155.00 746.00 756.00 688.00 802.00
Current
48.00 104.00 118.00 682.00 625.00 533.00 567.00
Non Current
9.00 16.00 36.00 63.00 131.00 154.00 235.00
Liabilities
103.00 192.00 248.00 122.00 199.00 240.00 254.00
Current
17.00 27.00 45.00 73.00 91.00 108.00 133.00
Non Current
85.00 165.00 203.00 49.00 108.00 131.00 120.00
Equity
-45.00 -71.00 -93.00 624.00 557.00 447.00 548.00
Stockholders' Equity
-45.00 -71.00 -93.00 624.00 557.00 447.00 548.00
Retained Earnings
-52.00 -80.00 -105.00 -129.00 -229.00 -379.00 -338.00
Common Stock
- - - - - - - - - - - - - -
Preferred Stock
- - - - 191.00 746.00 - - - - - -
Profit
-17.00 -28.00 -25.00 -26.00 -101.00 -149.00 40.00
Dividends
- - - - - - - - - - - - - -
Minority Interest
- - - - - - - - - - - - - -
Other Stockholders' Equity
15.00 8.00 -179.00 6.00 786.00 828.00 885.00
Loss Other Compr. Income
- - - - - - - - - - -2.00 - -
End of SDGR's Analysis
CIK: 1490978 CUSIP: 80810D103 ISIN: US80810D1037 LEI: - UEI: -
Secondary Listings
SDGR has no secondary listings inside our databases.